S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

AEZS Aeterna Zentaris Inc

1.95

-0.0025 (-0.13%)

After Hours

Last Updated: 15:20:01

Delayed by 15 minutes

AEterna Zentaris Rating Reiterated by Zacks (AEZS)

http://tickerreport.com/banking-finance/487361/aeterna-zentaris-rating-reiterated-by-zacks-aezs/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN

Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Aeterna Zentaris Charts.

Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Aeterna Zentaris Charts.

News

Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
Thursday 28 March 2024 (1 month ago) • GlobeNewswire Inc.

Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
Wednesday 27 March 2024 (1 month ago) • GlobeNewswire Inc.

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
Tuesday 12 March 2024 (2 months ago) • GlobeNewswire Inc.

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
Tuesday 12 March 2024 (2 months ago) • GlobeNewswire Inc.

Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company
Monday 26 February 2024 (2 months ago) • GlobeNewswire Inc.

Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceapro
Thursday 15 February 2024 (2 months ago) • GlobeNewswire Inc.

Form F-1 - Registration statement for certain foreign private issuers
Thursday 15 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
Thursday 15 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
Friday 22 December 2023 (4 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 14 December 2023 (5 months ago) • Edgar (US Regulatory)

Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company
Thursday 14 December 2023 (5 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 9 November 2023 (6 months ago) • Edgar (US Regulatory)

More News Articles

Virexit Technologies (PK)

Canopus Biopharma (PK)

Branded Legacy (PK)

Net Savings Link (PK)

Energy One (PK)

POET Technologies

Elite Pharmaceuticals (QB)

International Star (PK)

Cann American (CE)

Global Developments (PK)

Moon Equity (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions